Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Barnaby Pickering

Reporter, Medtech Insight

London, UK

Graduating in 2020 with a Master’s degree in biomedical engineering from University College London, Barnaby is passionate about all things medtech. In his first role as a journalist, Barnaby will focus on R&D and commercial stories in medtech, and writing about emerging technologies such as digital health, artificial intelligence, machine learning, deep-brain implants, and nanoscale applications of medtech. Alongside this, Barnaby is looking forward to taking deeper dives into start-ups, device market analysis, and company financial data, to create informed, useful, and engaging content.

Barnaby lives in in rural Wiltshire, UK and is a keen reader, cyclist, and hobbyist jeweler.

Latest From Barnaby Pickering

Inivata Continues Trials Of Its Liquid Biopsy Platform

The partnership with the Princess Margaret Cancer Center will support two studies of liquid biopsy testing for lung cancer.

In Vitro Diagnostics Cancer

Exec Chat: Abionic Is Accelerating Diagnostics To Save Lives

Abionic CEO Nicolas Durand explains how Abionic is filling unmet needs in diagnostics and the Swiss company’s plans for expansion.

Innovation In Vitro Diagnostics

Exec Chat: MeMed Improves Diagnostics To Combat Antimicrobial resistance

Kfir Oved, co-founder and CTO of MeMed, talked to Medtech Insight about diagnostic testing that can differentiate bacterial and viral infections to fight antimicrobial resistance.

C-Suite Speaks Innovation

Point Of Care Diagnostics Market Projected To Continue Rapid Growth

A new report from Informa's Meddevicetracker highlights strong projected growth in the market, explaining the underlying reasons why.

Market Intelligence In Vitro Diagnostics

Pear Therapeutics Obtains First Medicaid Coverage For PDTs

Massachusetts’ Medicaid program will cover reSET and reSET-O prescription digital therapeutics for the treatment of substance abuse disorder and opioid use disorder.

Reimbursement Telehealth

Medtech Companies Face Challenges And Choices When Going Public

In a panel discussion at The Medtech Conference, hosted by AdvaMed, CEOs discussed the challenges, benefits and technicalities surrounding an IPO.

Diversity & Inclusion Financing
See All
UsernamePublicRestriction

Register